Nick Lewis | Consultant
One Health Ventures Ltd

“Nick Lewis is an economics post-graduate from Cambridge University and a post-graduate from London Business School.  He is the Founder and Chairman of a private equity business, Downing LLP, which is based in London and has over £1 billion funds under management.

For the past five years, Nick has been funding the development of a novel genetic toxoid vaccine against epsilon toxin, which has been implicated as a trigger for multiple sclerosis in humans.  The toxin has long been known as the cause of Enterotoxaemia in sheep, which are routinely inoculated with a crude vaccine.  Nick is seeking partners to take forward the vaccine candidate through a first in human Phase 1 trial.”